142 related articles for article (PubMed ID: 8564726)
1. Terfenadine exerts antiallergic activity reducing ICAM-1 expression on nasal epithelial cells in patients with pollen allergy.
Ciprandi G; Pronzato C; Ricca V; Varese P; Del Giacco GS; Canonica GW
Clin Exp Allergy; 1995 Sep; 25(9):871-8. PubMed ID: 8564726
[TBL] [Abstract][Full Text] [Related]
2. Evidence of intercellular adhesion molecule-1 expression on nasal epithelial cells in acute rhinoconjunctivitis caused by pollen exposure.
Ciprandi G; Pronzato C; Ricca V; Bagnasco M; Canonica GW
J Allergy Clin Immunol; 1994 Oct; 94(4):738-46. PubMed ID: 7930308
[TBL] [Abstract][Full Text] [Related]
3. Topical azelastine reduces eosinophil activation and intercellular adhesion molecule-1 expression on nasal epithelial cells: an antiallergic activity.
Ciprandi G; Pronzato C; Passalacqua G; Ricca V; Grögen J; Mela GS; Varese P; Bertolini C; Bagnasco M; Canonica GW
J Allergy Clin Immunol; 1996 Dec; 98(6 Pt 1):1088-96. PubMed ID: 8977510
[TBL] [Abstract][Full Text] [Related]
4. Cetirizine treatment of rhinitis in children with pollen allergy: evidence of its antiallergic activity.
Ciprandi G; Tosca M; Ricca V; Passalacqua G; Riccio AM; Bagnasco M; Canonica GW
Clin Exp Allergy; 1997 Oct; 27(10):1160-6. PubMed ID: 9383256
[TBL] [Abstract][Full Text] [Related]
5. Seasonal rhinitis and azelastine: long- or short-term treatment?
Ciprandi G; Ricca V; Passalacqua G; Truffelli T; Bertolini C; Fiorino N; Riccio AM; Bagnasco M; Canonica GW
J Allergy Clin Immunol; 1997 Mar; 99(3):301-7. PubMed ID: 9058684
[TBL] [Abstract][Full Text] [Related]
6. Loratadine treatment of rhinitis due to pollen allergy reduces epithelial ICAM-1 expression.
Ciprandi G; Pronzato C; Ricca V; Passalacqua G; Danzig M; Canonica GW
Clin Exp Allergy; 1997 Oct; 27(10):1175-83. PubMed ID: 9383258
[TBL] [Abstract][Full Text] [Related]
7. Continuous antihistamine treatment controls allergic inflammation and reduces respiratory morbidity in children with mite allergy.
Ciprandi G; Ricca V; Tosca M; Landi M; Passalacqua G; Canonica GW
Allergy; 1999 Apr; 54(4):358-65. PubMed ID: 10371095
[TBL] [Abstract][Full Text] [Related]
8. Mizolastine and fexofenadine modulate cytokine pattern after nasal allergen challenge.
Ciprandi G; Cirillo I; Vizzaccaro A
Eur Ann Allergy Clin Immunol; 2004 Apr; 36(4):146-50. PubMed ID: 15180356
[TBL] [Abstract][Full Text] [Related]
9. A double-blind comparison of fluticasone propionate aqueous nasal spray, terfenadine tablets and placebo in the treatment of patients with seasonal allergic rhinitis to grass pollen.
Darnell R; Pecoud A; Richards DH
Clin Exp Allergy; 1994 Dec; 24(12):1144-50. PubMed ID: 7889428
[TBL] [Abstract][Full Text] [Related]
10. Intranasal fluticasone propionate reduces ICAM-1 on nasal epithelial cells both during early and late phase after allergen challenge.
Ciprandi G; Ricca V; Passalacqua G; Fasolo A; Canonica GW
Clin Exp Allergy; 1998 Mar; 28(3):293-9. PubMed ID: 9543078
[TBL] [Abstract][Full Text] [Related]
11. Topical levocabastine compared with orally administered terfenadine for the prophylaxis and treatment of seasonal rhinoconjunctivitis.
Søhoel P; Freng BA; Kramer J; Poppe S; Rebo R; Korsrud FR; Garud O; Woxen OJ; Olsen AK
J Allergy Clin Immunol; 1993 Jul; 92(1 Pt 1):73-81. PubMed ID: 8101534
[TBL] [Abstract][Full Text] [Related]
12. Azelastine eye drops reduce and prevent allergic conjunctival reaction and exert anti-allergic activity.
Ciprandi G; Buscaglia S; Catrullo A; Pesce G; Fiorino N; Montagna P; Bagnasco M; Canonica GW
Clin Exp Allergy; 1997 Feb; 27(2):182-91. PubMed ID: 9061218
[TBL] [Abstract][Full Text] [Related]
13. Cetirizine reduces ICAM-I on epithelial cells during nasal minimal persistent inflammation in asymptomatic children with mite-allergic asthma.
Fasce L; Ciprandi G; Pronzato C; Cozzani S; Tosca MA; Grimaldi I; Canonica GW
Int Arch Allergy Immunol; 1996 Mar; 109(3):272-6. PubMed ID: 8620097
[TBL] [Abstract][Full Text] [Related]
14. Effect of terfenadine and budesonide on nasal symptoms, olfaction, and nasal airway patency following allergen challenge.
Hilberg O
Allergy; 1995 Aug; 50(8):683-8. PubMed ID: 7503405
[TBL] [Abstract][Full Text] [Related]
15. Randomized double-blind comparison of cetirizine and fexofenadine after pollen challenge in the Environmental Exposure Unit: duration of effect in subjects with seasonal allergic rhinitis.
Day JH; Briscoe MP; Rafeiro E; Hewlett D; Chapman D; Kramer B
Allergy Asthma Proc; 2004; 25(1):59-68. PubMed ID: 15055564
[TBL] [Abstract][Full Text] [Related]
16. Effects of fexofenadine on inflammatory mediators in nasal lavage fluid in intermittent allergic rhinitis.
Schäper C; Gustavus B; Koch B; Ewert R; Hanf G; Kunkel G; Noga O; Gläser S
J Investig Allergol Clin Immunol; 2009; 19(6):459-64. PubMed ID: 20128420
[TBL] [Abstract][Full Text] [Related]
17. Allergen-specific challenge induces intercellular adhesion molecule 1 (ICAM-1 or CD54) on nasal epithelial cells in allergic subjects. Relationships with early and late inflammatory phenomena.
Ciprandi G; Pronzato C; Ricca V; Passalacqua G; Bagnasco M; Canonica GW
Am J Respir Crit Care Med; 1994 Dec; 150(6 Pt 1):1653-9. PubMed ID: 7524984
[TBL] [Abstract][Full Text] [Related]
18. Loratadine reduces the expression of ICAM-1.
Ciprandi G; Catrullo A; Cerqueti P; Tosca M; Fiorino N; Canonica GW
Allergy; 1998 May; 53(5):545-6. PubMed ID: 9636821
[No Abstract] [Full Text] [Related]
19. A comparison of topical levocabastine and oral terfenadine in the treatment of allergic rhinoconjunctivitis. The Livostin Study Group.
Allergy; 1993 Oct; 48(7):530-4. PubMed ID: 7902024
[TBL] [Abstract][Full Text] [Related]
20. Reduction of soluble ICAM-1 levels in nasal secretion by H1-blockers in seasonal allergic rhinitis.
Campbell A; Chanal I; Czarlewski W; Michel FB; Bousquet J
Allergy; 1997 Oct; 52(10):1022-5. PubMed ID: 9360756
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
